Lyell Immunopharma, Inc.
LYEL· Nasdaq
LYELLyell Immunopharma, Inc.
Quarterly figures for Lyell Immunopharma, Inc., with source filings when available.
25 quarters. Jun 30, 2020 to Jun 30, 2026. USD.
Lyell Immunopharma, Inc. has filed its 10-Q within 36 to 43 days of period end across its last 8 quarters. The 10-K runs 59 to 88 days.
Lyell Immunopharma, Inc. · CIK 1806952 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 · after-hours | Aug 6, 2026 | 37 d | 10-Q | $4.00K | −50.0% | -$1.92 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 6, 2026 · after-hours |
| May 6, 2026 |
| 36 d |
| 10-Q |
| $2.00K |
| −71.4% |
| -$1.10 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 12, 2026 · after-hours | Mar 12, 2026 | 71 d | 10-K | $6.00K | −45.5% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 12, 2025 · after-hours | Nov 12, 2025 | 43 d | 10-Q | $15.00K | −55.9% | -$2.13 | |
| Q2 2025 | Jun 30, 2025 | Aug 12, 2025 · after-hours | Aug 12, 2025 | 43 d | 10-Q | $8.00K | −38.5% | -$2.89 | |
| Q1 2025 | Mar 31, 2025 | May 13, 2025 · after-hours | May 13, 2025 | 43 d | 10-Q | $7.00K | +133.3% | -$3.54 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 11, 2025 · after-hours | Mar 11, 2025 | 70 d | 10-K | $11.00K | −15.4% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 7, 2024 · after-hours | Nov 7, 2024 | 38 d | 10-Q | $34.00K | +36.0% | -$3.48 | |
| Q2 2024 | Jun 30, 2024 | Aug 7, 2024 · after-hours | Aug 7, 2024 | 38 d | 10-Q | $13.00K | −51.9% | -$3.59 | |
| Q1 2024 | Mar 31, 2024 | May 6, 2024 · pre-market | May 6, 2024 | 36 d | 10-Q | $3.00K | −95.4% | -$0.24 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 28, 2024 · after-hours | Feb 28, 2024 | 59 d | 10-K | $13.00K | −100.0% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 7, 2023 · after-hours | Nov 7, 2023 | 38 d | 10-Q | $25.00K | +733.3% | -$0.20 | |
| Q2 2023 | Jun 30, 2023 | Aug 8, 2023 · after-hours | Aug 8, 2023 | 39 d | 10-Q | $27.00K | −99.9% | -$0.26 | |
| Q1 2023 | Mar 31, 2023 | May 4, 2023 · after-hours | May 4, 2023 | 34 d | 10-Q | $65.00K | −88.2% | -$0.27 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 28, 2023 · after-hours | Feb 28, 2023 | 59 d | 10-K | $48.39M | +1,614.6% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 8, 2022 · after-hours | Nov 8, 2022 | 39 d | 10-Q | $3.00K | −99.9% | -$0.28 | |
| Q2 2022 | Jun 30, 2022 | Aug 4, 2022 · after-hours | Aug 4, 2022 | 35 d | 10-Q | $35.74M | +1,260.0% | -$0.15 | |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 · after-hours | May 10, 2022 | 40 d | 10-Q | $553.00K | −77.4% | -$0.28 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 29, 2022 · after-hours | Mar 29, 2022 | 88 d | 10-K | $2.82M | — | — | |
| Q3 2021 | Sep 30, 2021 | Nov 12, 2021 · pre-market | Nov 12, 2021 | 43 d | 10-Q | $2.76M | +157.5% | -$0.20 | |
| Q2 2021 | Jun 30, 2021 | Aug 12, 2021 · after-hours | Aug 12, 2021 | 43 d | 10-Q | $2.63M | −15.7% | -$1.47 | |
| Q1 2021 | Mar 31, 2021 | — | — | — | — | $2.45M | — | -$3.19 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | — | — | — | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | $1.07M | — | -$2.57 | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | $3.12M | — | -$8.18 | |
